South East Asia Steps Up Fight Against TB
Executive Summary
South East Asia is gearing for additional momentum in the fight against TB, a disease that caused nearly 800,000 deaths in the region in 2015. Increased budgetary outlays, a regional “Innovation to Implementation” fund and the need for high impact interventions were among the key issues brought up at a recent ministerial meeting in India.
You may also be interested in...
Otsuka Ties Up With Mylan To Advance MDR-TB Drug In India?
Otsuka, which has been under fire over delayed access to delamanid in India, appears to have allied with Mylan, which has now secured a key clearance for the novel multidrug-resistant TB therapy in the country.
Indian Teen’s Fight For Lifesaving TB Drug Highlights Access Issues
An Indian teenager’s court battle for a new tuberculosis drug that doctors say could save her life has cast a harsh spotlight on the slow rollout of breakthrough medicines to treat the disease in the country, one of the world’s biggest TB hotspots.
INTERVIEW: Janssen India Boss On Sirturo Pricing And Real World Evidence
India has introduced Janssen's Sirturo, a poster child in the war against multidrug-resistant tuberculosis, through its Revised National Tuberculosis Control Program.